Matthew J. Hangauer

4.4k citations

21 papers · 3.2k indexed · 3 hit papers · h-index 16

Molecular Biology top 5%
Cancer Research top 1%
Organic Chemistry top 2%
Pulmonary and Respiratory Medicine top 5%
Oncology top 10%

Co-authors: Michael T. McManus Carolyn R. Bertozzi Frank McCormick Vasanthi S. Viswanathan Matthew J. Ryan Stuart L. Schreiber Dhruv Bole Jacqueline Galeas
Topics: Click Chemistry and Applications (7 papers)Glycosylation and Glycoproteins Research (4 papers)Advanced Fluorescence Microscopy Techniques (3 papers)
Cited by: Cancer Research Molecular Biology Organic Chemistry
Journals: Nature Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Russia Canada

In The Last Decade

Matthew J. Hangauer

20 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

2017 1.2k citations Matthew J. Hangauer, Vasanthi S. Viswanathan et al. Nature profile →
Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs

2013 574 citations Matthew J. Hangauer, Michael T. McManus et al. PLoS Genetics profile →
Metabolic cross-talk allows labeling of O-linked β- N -acetylglucosamine-modified proteins via the N -acetylgalactosamine salvage pathway

2011 273 citations Michael Boyce, Isaac S. Carrico et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Matthew J. Hangauer

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Hangauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Hangauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Hangauer more than expected).

Fields of papers citing papers by Matthew J. Hangauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Hangauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Hangauer. The network helps show where Matthew J. Hangauer may publish in the future.

Co-authorship network of co-authors of Matthew J. Hangauer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Hangauer. A scholar is included among the top collaborators of Matthew J. Hangauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Hangauer. Matthew J. Hangauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth 2025 ·Nature Cell Biology ·August Williams,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jennifer L. Page,Matthew J. Hangauer	0
2	Abstract 99: Apoptotic DNase DFFB mediates cancer persister cell mutagenesis and acquired drug resistance 2023 ·Cancer Research ·(unknown),(unknown),(unknown),(unknown),Michael Wang,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jennifer L. Page,Matthew J. Hangauer	2
3	High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions 2019 ·Cell Reports ·Marsilius Mues,Laila Karra,Damià Romero–Moya,Anica M. Wandler,Matthew J. Hangauer,(unknown),(unknown),(unknown),Kevin Shannon,Michael T. McManus,Jeroen P. Roose	5
4	Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibitionbreakdown → 2017 ·Nature ·Matthew J. Hangauer,Vasanthi S. Viswanathan,Matthew J. Ryan,Dhruv Bole,John K. Eaton,Alexandre Matov,Jacqueline Galeas,Harshil Dhruv,Michael E. Berens,Stuart L. Schreiber,Frank McCormick,Michael T. McManus	1204
5	Abstract 1006: Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition 2017 ·Cancer Research ·Matthew J. Hangauer,Vasanthi S. Viswanathan,Matthew J. Ryan,Dhruv Bole,(unknown),Stuart L. Schreiber,Frank McCormick,(unknown)	2
6	Drug Resistance to EGFR Inhibitors in Lung Cancer 2016 ·Chemotherapy ·Osamu Tetsu,Matthew J. Hangauer,Janyaporn Phuchareon,David W. Eisele,Frank McCormick	56
7	Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAsbreakdown → 2013 ·PLoS Genetics ·Matthew J. Hangauer,(unknown),Michael T. McManus	574
8	A Chemical Glycoproteomics Platform Reveals O-GlcNAcylation of Mitochondrial Voltage-Dependent Anion Channel 2 2013 ·Cell Reports ·Krishnan K. Palaniappan,Matthew J. Hangauer,Timothy J. Smith,Brian P. Smart,Austin A. Pitcher,Emily H. Cheng,Carolyn R. Bertozzi,Michael Boyce	28
9	Research Resource: RNA-Seq Reveals Unique Features of the Pancreatic β-Cell Transcriptome 2012 ·Molecular Endocrinology ·Gregory Ku,Hail Kim,(unknown),Matthew J. Hangauer,Chang‐Myung Oh,Michael S. German,Michael T. McManus	90
10	Fluorogenic Azidofluoresceins for Biological Imaging 2012 ·Journal of the American Chemical Society ·Peyton Shieh,Matthew J. Hangauer,Carolyn R. Bertozzi	132
11	Metabolic cross-talk allows labeling of O-linked β- N -acetylglucosamine-modified proteins via the N -acetylgalactosamine salvage pathwaybreakdown → 2011 ·Proceedings of the National Academy of Sciences ·Michael Boyce,Isaac S. Carrico,(unknown),Seok‐Ho Yu,Matthew J. Hangauer,S C Hubbard,Jennifer J. Kohler,Carolyn R. Bertozzi	273
12	Live‐Cell Imaging of Cellular Proteins by a Strain‐Promoted Azide–Alkyne Cycloaddition 2010 ·ChemBioChem ·Kimberly E. Beatty,John D. Fisk,Brian P. Smart,Ying Y. Lu,Janek Szychowski,Matthew J. Hangauer,Jeremy M. Baskin,Carolyn R. Bertozzi,David A. Tirrell	136
13	Correction to Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxC 2009 ·Biochemistry ·Adam W. Barb,(unknown),Lori I. Robins,Ziqiang Guan,David A. Six,Pei Zhou,Matthew J. Hangauer,Carolyn R. Bertozzi,Christian R.H. Raetz	2
14	A FRET‐Based Fluorogenic Phosphine for Live‐Cell Imaging with the Staudinger Ligation 2008 ·Angewandte Chemie ·Matthew J. Hangauer,Carolyn R. Bertozzi	51
15	A FRET‐Based Fluorogenic Phosphine for Live‐Cell Imaging with the Staudinger Ligation 2008 ·Angewandte Chemie International Edition ·Matthew J. Hangauer,Carolyn R. Bertozzi	159
16	Imaging Cell Surface Glycans with Bioorthogonal Chemical Reporters 2007 ·Journal of the American Chemical Society ·Pamela V. Chang,Jennifer A. Prescher,Matthew J. Hangauer,Carolyn R. Bertozzi	173
17	Identification of palmitoylated mitochondrial proteins using a bio‐orthogonal azido‐palmitate analogue 2007 ·The FASEB Journal ·Morris A. Kostiuk,María M. Corvi,Bernd O. Keller,(unknown),Jennifer A. Prescher,Matthew J. Hangauer,Carolyn R. Bertozzi,(unknown),John R. Falck,Luc G. Berthiaume	123
18	Metabolic Labeling of Glycans with Azido Sugars for Visualization and Glycoproteomics 2006 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Scott T. Laughlin,Nicholas J. Agard,Jeremy M. Baskin,Isaac S. Carrico,Pamela V. Chang,(unknown),Matthew J. Hangauer,(unknown),Jennifer A. Prescher,Carolyn R. Bertozzi	121
19	Nonacid cleavable detergents applied to MALDI mass spectrometry profiling of whole cells 2005 ·Journal of Mass Spectrometry ·Jeremy L. Norris,Matthew J. Hangauer,Ned A. Porter,Richard M. Caprioli	16
20	The design, synthesis and activity of non-ATP competitive inhibitors of pp60c-src tyrosine kinase. Part 2: Hydroxyindole derivatives 2000 ·Bioorganic & Medicinal Chemistry Letters ·Karen L. Milkiewicz,Thomas H. Marsilje,(unknown),Neil Bifulco,Matthew J. Hangauer,David Hangauer	29

About Matthew J. Hangauer

Matthew J. Hangauer is a scholar working on Biophysics, Organic Chemistry and Molecular Biology, having authored 21 papers that have together received 3.2k indexed citations. Recurring topics across this work include Click Chemistry and Applications (7 papers), Glycosylation and Glycoproteins Research (4 papers) and Advanced Fluorescence Microscopy Techniques (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.4k citations) and Organic Chemistry (841 citations). Matthew J. Hangauer has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Michael T. McManus, Carolyn R. Bertozzi, Frank McCormick, Vasanthi S. Viswanathan, Matthew J. Ryan, Stuart L. Schreiber, Dhruv Bole, Jacqueline Galeas, Michael E. Berens and Alexandre Matov. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact